Romanian Society of Nephrology Report issue

Academic/Hospital

Organization Overview

First Clinical Trial
2004
NCT00349960
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2012

Timeline

NOW
  • Now

Active Ingredients

Drugs in Other Trials (3)

calcium (1 trial)

darbepoetin beta (1 trial)

sevelamer (renagel) (1 trial)

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 2
  • # of Trial APIs: 3